These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 35877216)

  • 1. Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep's Clothing?
    Mitsala A; Tsalikidis C; Romanidis K; Pitiakoudis M
    Curr Oncol; 2022 Jun; 29(7):4478-4510. PubMed ID: 35877216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease: A sign of systemic disease.
    Reccia I; Kumar J; Akladios C; Virdis F; Pai M; Habib N; Spalding D
    Metabolism; 2017 Jul; 72():94-108. PubMed ID: 28641788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and Dysbiosis.
    Scorletti E; Byrne CD
    Dig Dis; 2016; 34 Suppl 1():11-8. PubMed ID: 27548822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
    Zoller H; Tilg H
    Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers.
    Ibrahim MK; Simon TG; Rinella ME
    Clin Liver Dis; 2023 May; 27(2):251-273. PubMed ID: 37024206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
    Dhamija E; Paul SB; Kedia S
    Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
    Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
    Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship.
    Muzica CM; Sfarti C; Trifan A; Zenovia S; Cuciureanu T; Nastasa R; Huiban L; Cojocariu C; Singeap AM; Girleanu I; Chiriac S; Stanciu C
    Can J Gastroenterol Hepatol; 2020; 2020():6638306. PubMed ID: 33425804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC.
    Liu K; McCaughan GW
    Adv Exp Med Biol; 2018; 1061():3-18. PubMed ID: 29956203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers.
    Sanna C; Rosso C; Marietti M; Bugianesi E
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Thomas JA; Kendall BJ; Dalais C; Macdonald GA; Thrift AP
    Eur J Cancer; 2022 Sep; 173():250-262. PubMed ID: 35944373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.
    Stefan N; Häring HU; Cusi K
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):313-324. PubMed ID: 30174213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease.
    Powell EE; Wong VW; Rinella M
    Lancet; 2021 Jun; 397(10290):2212-2224. PubMed ID: 33894145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common features of the metabolic syndrome and nonalcoholic fatty liver disease.
    Almeda-Valdes P; Aguilar-Olivos N; Uribe M; Méndez-Sánchez N
    Rev Recent Clin Trials; 2014; 9(3):148-58. PubMed ID: 25514910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease and dyslipidemia: An update.
    Katsiki N; Mikhailidis DP; Mantzoros CS
    Metabolism; 2016 Aug; 65(8):1109-23. PubMed ID: 27237577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease].
    Kwon OS; Kim JH; Kim JH
    Korean J Gastroenterol; 2017 Jun; 69(6):348-352. PubMed ID: 28637103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.